2[2]Berman D S, Kiat H, van Train K, et al. Technetium 99m sestamibi in the assessment of chronic coronary artery disease. Semin Nucl Med, 1991,21:190-212.
3[3]Harada K, Grossman W, Friedman M, et al. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Invest, 1994,94:623-630.
4[4]Banai S, Jaklitsch M T, Shou M, et al. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation, 1994,89:2183-2139.
5Jaffrumi NA, Ehrenpreis S, Ladd UA, et al.Jherapeutic approach to unstable angina nitroglycerin, heparin and combined therapy. Am Hetra J, 1993, 126 (15): 12-39.
6Lew is HJ, Day is TW, A rchibald DG, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina: results of Velerans Adm in istration co- orperative study. N Engl J Med,1983, 309 (7): 396.
7The RISC Group. Rise of myocardial infarction and death during treament with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet, 1990, 336(8719) : 827.
8Shaldos. Koch. KM Survival and adequacy in Long - term hemodialysis. Nephron, 1991, 59:353.
9Schrader J, Stifle W, Armstrong V, et al.Comparison of low molecular weight heparln to Standard in hemodialysis/hemofiltration kindney Int, 1988, 33:890.
6Kyriakides ZS, Kourouklis S, Kontaras K. Acute coronary syndromes in the elderly[ J]. Drugs Aging, 2007,24( 11 ) :901 - 912.
7Anghasuwapala K, Ratanasumawong K, Ngarmukos T, etal. Effect of unfractionated heparin and low molecular weight heparin on hospital mortality in patients with non ST elevation acute coronary syndrome(ACS)[J] .J Med Assoc Thai,2007,90(Suppl 1):109 - 114.
8LaPointe NM, Chen AY, Alexander KP, et al. Enoxaparin dosing and associated risk .of in-hospital bleeding and death in patients with non ST-segment elevation acute coronary syndromes[J]. Arch Intern Med, 2007, 165 (14): 1539 - 1544.
